CSB601 - Analyzing Patient Case Study with ASE-C-POP Framework 2018

This assignment presents a case study involving a patient, Mary, and analyzes her current medications using the ASE-C-POP framework. The analysis identifies several potential and actual medication-related issues, including the ineffectiveness of current treatments for blood pressure and chest pain, as well as safety concerns regarding the use of Metformin and Metoprolol in a patient with a cardiac disorder and type II diabetes. The assignment highlights the importance of considering potential side effects and drug interactions when prescribing medications, and emphasizes the need for a comprehensive and effective therapeutic plan that addresses the patient's specific needs and medical history. The assessment concludes that the current medication regimen is not safe or effective, necessitating immediate attention and adjustments to improve the patient's health outcomes.

CSB601 2018 Group assignment
Group Name, Case Patient Chosen (Mary or Dennis)
Workshop Day, Workshop Time, Group #
Group Leader Name, Student Number
Team Member 2 Name, Student Number
Team Member 3 Name, Student Number
Team Member 4 Name, Student Number
Team Member 5 Name, Student Number
Team Member 6 Name, Student Number

ASE-C-POP
Appropriate
On thoroughly analysing the case study, it can be said that the drugs that are prescribed to Mary have the
following effects:
Metformin CR 2g daily : In order to control Type II Diabetes
Perindopril 5mg daily (started 2 years ago) : In order to control the elevated Blood Pressure
Metoprolol CR 47.5mg daily (started several months ago): To control chest pain
Furosemide 40mg daily (started several months ago) : To treat fluid build-up in the chest
Diclofenac 50 mg 1 tablet three times daily (started last week): In order to provide pain relief and reduce
inflammation
 On studying the current medication that is being administered to the patient, it can be said that
the patient is regularly taking Perindropil but the elevated blood pressure is still not under
control.
 The administration of Metformin for treating Diabetes type II has long been obsolete
specifically to patients who have a cardiac disorder.
 It should also be noted that despite taking Metoprolol for a several months, the chest pain has
yet not been under control and the patient is complaining of shortness of breath.
Safe
 The administration of Metformin to treat Diabetes type II in individuals with heart disorder is
not safe as it impedes with the proper cardiac functioning [1]
 Administration of Metoprolol is absolutely not safe for patients who are suffering from Diabetes
type II or possess a heart failure history as per the QUM as it can seriously affect the glucose
level in the blood [2],[3].
Hence, it can be said that the drugs that have been prescribed are impeding with the normal
physiological functions of the body and are eliciting severe side-effects. Hence, the issue should be
addressed immediately.
ective
It can be said that the present medication that is being used for the patient is not effective as it is eliciting
side effects and hampering the normal body functioning.

References
American Diabetes Association. Standards of medical care in diabetes—2014. Diabetes care. 2014 Jan
1;37(Supplement 1):S14-80.
Weber, M.A., Schiffrin, E.L., White, W.B., Mann, S., Lindholm, L.H., Kenerson, J.G., Flack, J.M., Carter, B.L.,
Materson, B.J., Ram, C.V.S. and Cohen, D.L., 2014. Clinical practice guidelines for the management of
hypertension in the community: a statement by the American Society of Hypertension and the International
Society of Hypertension. The journal of clinical hypertension, 16(1), pp.14-26.
UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on
complications in overweight patients with type 2 diabetes (UKPDS 34). The Lancet. 1998 Sep
12;352(9131):854-65.